NASDAQ: TDACTranslational Development Acquisition Corp Stock
$10.75+0.01 (+0.09%)
Updated Jun 18, 2026
TDAC Price
$10.75
Fair Value Price
N/A
Market Cap
$235.51M
52 Week Low
$10.27
52 Week High
$10.80
P/E
38.39x
P/B
-34.52x
P/S
N/A
PEG
0.11x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$6.21M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$682k
Beta
-0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TDAC Overview
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TDAC's potential to beat the market
- TDAC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
TDAC
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.80 | C | |
| $11.14 | C | |
| $12.57 | C |
Be the first to know about important TDAC news, forecast changes, insider trades & much more!
TDAC News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TDAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TDAC ($10.75) is trading below its intrinsic value of $32.96, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TDAC is poor value based on its earnings relative to its share price (38.39x), compared to the US market average (9.47x)
P/E vs Market Valuation
TDAC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more TDAC due diligence checks available for Premium users.
Valuation
TDAC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
38.39x
Industry
15.56x
Market
9.47x
TDAC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TDAC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
TDAC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-34.52x
Industry
78.31x
TDAC price to earnings growth (PEG)
For valuing profitable companies with growth potential
TDAC is good value based... subscribe to Premium to read more.
PEG Value Valuation
TDAC's financial health
Profit margin
Revenue
$0.0
Net Income
$1.3M
Profit Margin
0%
TDAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$183.3M
Liabilities
$6.9M
Debt to equity
-1.01
TDAC's short-term liabilities ($861.09k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TDAC's long-term liabilities ($6.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TDAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TDAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$305.2k
Investing
$0.0
Financing
$300.0k
TDAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TDAC vs Shell Company Stocks
Translational Development Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.